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Chronic right ventricular (RV) pacing may lead to both RV
and left ventricular (LV) dysfunction (LV ejection fraction
[EF] o40%) and improve with biventricular pacing. The
role of cardiac resynchronization therapy (CRT) in isolated
RV dysfunction has not been reported. We demonstrate that
pacemaker-induced isolated RV failure responds to CRT, as
proven by intracardiac hemodynamics and symptom
improvement within 2 months after the procedure.Case report
A 45-year-old previously healthy and physically active
attorney presented to a local hospital with symptoms of
acute dizziness, dyspnea, and fatigue while mowing his
lawn. Serial ECGs revealed sinus rhythm with left bundle
branch block (Figure 1A) and second-degree AV block with
incomplete right bundle branch block (Figure 1B). A dual-
chamber pacemaker was urgently placed, with resolution of
symptoms. Over a 5-year period, he developed progressive
exertional dyspnea (1 ﬂight of stairs) and fatigue New York
Heart Association (NYHA) functional class IIIB heart fail-
ure. He sought help at our institution. His blood pressure was
132/82 mm Hg, heart rate 70–106 bpm (89% paced), and he
was taking no cardiac medications. Physical examination
was unremarkable. Transthoracic echocardiography revealed
mildly impaired LV systolic function (EF ¼ 50%) with no
hemodynamically signiﬁcant valve disease. Cardiac com-
puted tomography showed an Agatston score of 0 with leftKEYWORDS Right ventricular failure; Pacemaker; Cardiac resynchronization
therapy
ABBREVIATIONS CRT¼ cardiac resynchronization therapy; EF¼ ejection
fraction; LV ¼ left ventricle; NYHA ¼ New York Heart Association;
RV ¼ right ventricle (Heart Rhythm Case Reports 2015;1:182–185)
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).dominant anatomy and normal coronaries (Figures 1C and 1D),
dilated RV chamber size with decreased RV EF to 40%
(Figures 1E and 1F), and an aneurysmal interatrial septum.
LV dyssynchrony could not be appreciated. Transesophageal
echocardiography conﬁrmed RV global hypokinesis, mild
tricuspid regurgitation, and no intracardiac shunt.
The patient underwent cardiopulmonary testing, during
which he achieved maximal exercise with an appropriate
chronotropic response and peak heart rate of 179 bpm.
Hemoglobin was 15.6 g/dL (normal 13.2–17.7 g/dL), but
peak VO2 was decreased (73% of predicted) and O2/pulse
was low (71% of predicted). Anaerobic threshold measured
by the V-slope method was low–normal (42%) in the
absence of a ventilatory or gas exchange limitation to
exercise. Right heart catheterization (Figure 2) showed a
decreased cardiac index of 1.56 L/min/m2 (normal 2.8–4.2
L/min/m2), elevated mean right atrial pressure of 11 mm Hg
(normal –1 to þ8 mm Hg), normal pulmonary capillary
wedge pressure of 12 mm Hg (normal 6–15 mm Hg), and
mean pulmonary arterial pressure of 16 mm Hg (normal
10–22 mm Hg). Interestingly, the Kussmaul sign was present.
We suspected that predominant RV pacing over time led
to isolated RV failure as the explanation for his symptoms
and discussed implantation of a cardiac resynchronization
therapy device. He agreed to undergo the procedure even
though a positive outcome could not be guaranteed. Two
weeks after the procedure, the patient reported a dramatic
improvement in symptoms and overall functional capacity.
Repeat right heart catheterization 2 months later revealed
normal right-sided ﬁlling pressures, and the Kussmaul sign
was absent. Six months later, histograms demonstrated an
increase in the percentage of lower heart rates (Figure 3A).
Comparison of representative 24-hour densitometry plots
before and after the procedure showed an increase in heart
rate variability with CRT therapy (Figure 3B). Despite
improvement in symptoms and RV function, cardiac
index remained low and prompted further evaluation
for possible subclinical inﬁltrative pathology, including
light-chain amyloidosis, cardiac sarcoidosis, collagenpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.01.021
KEY TEACHING POINTS
 Pacemaker-induced isolated right ventricular (RV)
failure quickly responds to cardiac
resynchronization therapy (CRT).
 Hemodynamic assessment and right heart
catheterization are superior to standard imaging
modalities such as echocardiography, cardiac
computed tomography, and cardiopulmonary
testing in diagnosing isolated pacemaker-induced
RV failure.
 CRT has beneﬁts beyond left ventricular
improvement.
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testing using a comprehensive arrhythmia panel, which was
unrevealing.Discussion
Based on the 2012 ACCF/AHA/HRS focused update incor-
porated into the 2008 guidelines for device-based therapy of
cardiac rhythm abnormalities, biventricular pacing isFigure 1 Left: baseline. ECGs of a symptomatic patient show left bundle branc
after dual-chamber pacemaker implantation. Volume-rendered dual-source comp
nondominant right coronary artery (D). Four-chamber views obtained during sys
fractional shortening. Right ventricular pacemaker lead creates metal artifacts. LAcurrently recommended for selected patients with LV
systolic heart failure and NYHA class III/IV symptoms, QRS
Z130ms, and baseline impaired LV function (EFo40%).1,2
The guidelines recognize that selected patients, especially
younger individuals with normal baseline LV EF, may
experience deterioration in LV contractile function due to
chronic RV pacing, and the guidelines question whether
these patients would also beneﬁt from initial implantation of
a biventricular device, future device upgrade, or alternative
sites of ventricular pacing.3
More recent studies have focused on the effect of CRT
on RV function and remodeling. MADIT-CRT investiga-
tors showed a signiﬁcant improvement in RV function in
parallel with improvement in LV function in patients
with only mild heart failure symptoms (NYHA I/II), low
EF, and a wide QRS complex who were randomized to
CRT plus implantable cardioverter-deﬁbrillator therapy at
1 year or to implantable cardioverter-deﬁbrillator therapy
alone.4
Our patient had dramatically improved symptoms and
quality of life soon after biventricular pacing. The key data
supporting such a decision were derived from right heart
catheterization. Intracardiac pressures clearly revealed pri-
mary RV failure most likely due to pacing, supported by the
Kussmaul sign in the absence of LV dysfunction orh block (A) and incomplete right bundle branch block (B). Right: Five years
uted tomographic images show plaque-free left dominant system (C) and
tole (E) and diastole (F) show right-sided chamber enlargement and poor



















60 days post CRT
Right atrial mean pressure 
(mmHg)
11 4
24/13 17/7Right ventricular pressure 
(systolic/diastolic) mmHg
Pulmonary artery pressure 
(systolic/diastolic/mean) mmHg
24/13/16 17/7/10
Pulmonary capillary wedge pressure  
(mean) mmHg 12 5
Kussmaul’s sign                                                                                
Systemic vascular resistance (dyn.s/cm5) 1953.05 2046.35
Pulmonary vascular resistance index 
(dyn.s/cm5/m2)
1.13 1.34
Cardiac output ( Thermodiluon; L/min/m2) 3.0 3.01
Cardiac index (Thermodiluon; L/min/m2) 1.56 1.57
Cardiac output ( Fick; L/min) 3.55 3.74
Cardiac index (Fick; L/min) 1.85 1.95
Pulmonary artery saturaon sat % 61 64
Heart rate (bpm) 69 86
Ejecon fracon % (2D Echo) 50% 50%
5 years aer pacemaker
AbsentInspiraon
Expiraon
Figure 2 Effect of biventricular pacing on right-sided hemodynamics in a symptomatic patient with preserved left ventricular ejection fraction. Five years after
dual-chamber pacemaker implantation, right atrial pressure was elevated and rose further with inspiration, consistent with Kussmaul sign and underlying primary
right ventricular failure. Two months after cardiac resynchronization therapy (CRT) upgrade, right-sided ﬁlling pressures normalized, Kussmaul sign was absent,
but baseline low cardiac index did not respond to resynchronization therapy.
Heart Rhythm Case Reports, Vol 1, No 4, July 2015184pulmonary hypertension. Repeat cardiac catheterization 2
months after resynchronization therapy showed normal right
atrial and RV ﬁlling pressures and no Kussmaul sign.
The role of CRT in isolated RV dysfunction has not
been reported. Our case suggests that CRT has beneﬁtsbeyond LV improvement and may help other patients
with preserved LV EF who develop symptomatic primary
RV failure due to pacing. However, more studies are
required before we can recommend a change in future
guidelines.
Figure 3 Effect of biventricular pacing on heart rate variability and sympathetic tone. A:Within the ﬁrst month of cardiac resynchronization therapy (CRT),
the majority of resting heart rates stayed within the range of 80–90 bpm. Six months later, periods of lower heart rates (60–70 bpm) signiﬁcantly increased.
B: Representative 24-hour densitometry plots show very subtle increases in heart rate variability and increases in lower-frequency rates after CRT.
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